The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2RS,3RS)-2-(4-Chlorophenyl)-N-(2-hydroxyethyl)-5-oxo-1-(4-sulfamoylphenyl)pyrrolidine-3-carboxamide ID: ALA4476050
PubChem CID: 155538083
Max Phase: Preclinical
Molecular Formula: C19H20ClN3O5S
Molecular Weight: 437.91
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: NS(=O)(=O)c1ccc(N2C(=O)C[C@H](C(=O)NCCO)[C@H]2c2ccc(Cl)cc2)cc1
Standard InChI: InChI=1S/C19H20ClN3O5S/c20-13-3-1-12(2-4-13)18-16(19(26)22-9-10-24)11-17(25)23(18)14-5-7-15(8-6-14)29(21,27)28/h1-8,16,18,24H,9-11H2,(H,22,26)(H2,21,27,28)/t16-,18+/m0/s1
Standard InChI Key: ZTNPVYBROJICQU-FUHWJXTLSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
4.3666 -13.0049 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1838 -13.0049 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.7752 -12.2972 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.7834 -17.5325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6006 -17.5325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8550 -16.7558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1920 -16.2737 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5333 -16.7558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1908 -15.4566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8995 -15.0475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8986 -14.2311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1898 -13.8228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4803 -14.2368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4847 -15.0519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8218 -16.3438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3666 -18.2382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5495 -18.2301 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.7682 -18.9499 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5582 -16.3397 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8256 -15.5206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1150 -15.1087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4015 -15.5190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4031 -16.3453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1143 -16.7535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8940 -12.5950 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.6938 -15.1104 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
5.5853 -18.9580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9869 -19.6697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8041 -19.6778 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 4 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
7 9 1 0
8 15 1 1
4 16 1 6
16 17 2 0
16 18 1 0
6 19 2 0
15 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 15 1 0
12 2 1 0
2 25 1 0
22 26 1 0
18 27 1 0
27 28 1 0
28 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 437.91Molecular Weight (Monoisotopic): 437.0812AlogP: 1.19#Rotatable Bonds: 6Polar Surface Area: 129.80Molecular Species: NEUTRALHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.24CX Basic pKa: ┄CX LogP: 0.40CX LogD: 0.40Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.62Np Likeness Score: -1.11
References 1. Kalinin S, Nocentini A, Kovalenko A, Sharoyko V, Bonardi A, Angeli A, Gratteri P, Tennikova TB, Supuran CT, Krasavin M.. (2019) From random to rational: A discovery approach to selective subnanomolar inhibitors of human carbonic anhydrase IV based on the Castagnoli-Cushman multicomponent reaction., 182 [PMID:31476557 ] [10.1016/j.ejmech.2019.111642 ]